Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDM Chamber Exposure in Atopic Dermatitis
NCT05019209Completed
- Sponsor
- Fraunhofer ITEM
- Start
- Sep 2021
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
Randomised, single-blind trial, sponsored by Fraunhofer ITEM. Primary endpoint: Change in the objective SCORAD. Started Sep 2021; status: completed.
Beyond the preview
Go deeper on NCT05019209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05019209.